CEREVASC
CereVasc is a medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases. Current treatment of these patients requires an invasive, neurosurgical procedure with a documented rate of success well below the success rate for other neurosurgical interventions. The eShunt System has the potential to significantly improve patient outcomes and substantially decrease the overall cost of surgical treatment of this life-threatening condition.
CEREVASC
Industry:
Biotechnology Health Care Medical Device
Founded:
2014-01-01
Address:
Auburndale, Massachusetts, United States
Country:
United States
Website Url:
http://www.cerevasc.com
Total Employee:
11+
Status:
Active
Total Funding:
44 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager WordPress Google Universal Analytics Global Site Tag Sitelinks Search Box Yoast WordPress SEO Plugin Google Maps
Similar Organizations
Braeburn
Braeburn is dedicated to delivering solutions for people living with the serious consequences of opioid use disorder.
Homology Medicines
Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.
InVivo Therapeutics
InVivo Therapeutics is a medical device company focused on developing restoration treatments for patients with spinal cord-injuries.
MedNews
MedNews is a medical device company developing treatments for patients with heart failure.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Tandem Diabetes Care
Tandem diabetes care provides products that empower both people with diabetes and those who care for them.
Turn Medical
Turn Medical is a medical device company delivering healthcare solutions from patients to clinicians.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Investors List
ATON Partners
ATON Partners investment in Series A - CereVasc
Perceptive Advisors
Perceptive Advisors investment in Series A - CereVasc
Official Site Inspections
http://www.cerevasc.com
- Host name: 61.171.211.130.bc.googleusercontent.com
- IP address: 130.211.171.61
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "CereVasc"
CereVasc - Crunchbase Company Profile & Funding
CereVasc is a medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases. Current …See details»
CereVasc - LinkedIn
CereVasc | 3,781 followers on LinkedIn. A company focused on the development of novel, minimally invasive treatments for patients with neurological disease | CereVasc, Inc. is developing the ...See details»
CereVasc Org Chart + Executive Team - The Official Board
Organizational Chart of CereVasc. CereVasc Org Chart cerevasc.com. has 17 executives +1 617 921 0808; Add an executive. CereVasc News . Anything missing? We search for you. Print or …See details»
CereVasc 2025 Company Profile: Valuation, Funding
CereVasc General Information Description. Operator of a medical device company intended to treat patients with neurological diseases. The company's …See details»
CereVasc, LLC Receives Approval to Initiate First-in-Human Clinical ...
Nov 4, 2019 CereVasc, LLC Receives Approval to Initiate First-in-Human Clinical Study of the eShunt™ System. November 4, 2019, Boston, MA. CereVasc, LLC, a company focused on …See details»
Tufts Medical Center Neurosurgeons and CereVasc Co-founders …
Nov 21, 2022 Tufts Medicine is the parent organization of Tufts Medical Center, ... CereVasc, Inc., is a clinical-stage, venture-funded, medical device company focused on the development …See details»
CereVasc - Overview, News & Similar companies | ZoomInfo.com
May 7, 2024 Who is CereVasc. CereVasc, Inc. is a medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseas es. …See details»
CereVasc, Inc. Receives FDA Breakthrough Device Designation for …
7 hours ago CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, today announced it has received its second …See details»
CereVasc Company Profile - Office Locations, Competitors ... - Craft
CereVasc is a company focused on improving the treatment of patients with hydrocephalus. Its eShunt System comprises an endovascularly implantable CSF shunt and associated delivery …See details»
Cerevasc - Bain Capital Life Sciences
CereVasc is a clinical stage, medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases. Its initial product, the …See details»
CereVasc - Funding, Financials, Valuation & Investors - Crunchbase
CereVasc is a medical device company focused on improving the treatment of patients with hydrocephalus. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. ... How …See details»
Tufts Medical Center Neurosurgeons and CereVasc Co-founders …
Nov 21, 2022 Tufts Medicine is the parent organization of Tufts Medical Center, ... CereVasc, Inc., is a clinical-stage, venture-funded, medical device company focused on the development …See details»
First patient treated in CereVasc® clinical trial of eShunt® System …
BOSTON, April 25, 2022 /PRNewswire/ -- CereVasc, Inc., a ... and National Stroke Prevention Campaign in line with the World Stroke Organization at the Comprehension Stroke Center of ...See details»
CereVasc, Inc. Receives FDA Breakthrough Device Designation for …
7 hours ago About CereVasc, Inc. Located in Massachusetts' healthcare hub, CereVasc, Inc., is a clinical stage, medical device company focused on the development of novel, minimally …See details»
CereVasc | neurological diseases, CereVasc, Zoonop
CereVasc operates under a comprehensive business model focusing on the development and clinical validation of its medical devices, specifically targeting neurological disorders like …See details»
CereVasc Announces Closing of $43.9 Million Series A Financing
Jun 9, 2020 BOSTON–(BUSINESS WIRE)–CereVasc, Inc., a company focused on improving the treatment of patients with hydrocephalus, announced today the closing of an expanded …See details»
CereVasc Announces $70 Million Series B Financing to Advance its …
May 13, 2024 “CereVasc has a distinct opportunity to dramatically improve the care of patients with hydrocephalus. We look forward to partnering with Dan and his team to bring this …See details»
Medical device startup CereVasc lands $43.9M - PitchBook
Jun 10, 2020 Medical device startup CereVasc lands $43.9M. June 10, 2020. Share: CereVasc has collected $43.9 million in a Series A co-led by Perceptive Advisors and Aton Partners. The …See details»
CereVasc's Minimally Invasive Central Nervous System Therapy …
BOSTON, June 14, 2023 /PRNewswire/ — CereVasc, Inc., a privately held, clinical-stage, medical device company developing novel treatments for neurological diseases, announced today that …See details»
CereVasc to Present Data on its Minimally Invasive CNS Delivery …
BOSTON, May 4, 2023 /PRNewswire/ — CereVasc, Inc., a privately held, clinical-stage, medical device company developing novel treatments for neurological diseases, announced today that …See details»